A collaborative, solutions-driven partnership, featuring end-to-end support of clinical trials is now underway between Celerion and OmniComm Systems, Inc. The partnership represents a major milestone in Celerion’s search for a trusted niche partner to facilitate the transport of clinical research initiatives from concepts to marketplace realities. A key aspect of that journey includes a complete transformation of Celerion’s data into fully automated electronic records, and Celerion has selected OmniComm Systems for that role. The collaboration will yield multiple benefits for both companies and provide Celerion with the opportunity to further enhance the efficiency of its clinical trials and contribute to greater patient safety and improved outcomes. Using the TrialMaster OmniConnect integration toolset, Celerion’s Phase I clinical data is transferred directly from Celerion’s ClinQuick data acquisition platform into the TrialMaster EDC platform. The extensive benefits derived by this eSource solution include reduced need for data entry, enhanced accuracy of EDC data, and faster time to review, report and analyze the clinical data. OmniComm was selected for the partnership based on the company’s EDC solutions, which offer inherent flexibility and broad capabilities to support clinical studies across all phases of clinical development. Deploying studies in an efficient, timely and cost-effective manner was especially important to Celerion. OmniComm’s robust, state-of-the art, compliant hosting environment was another critical factor in the selection process.